Skip to content
Sign in
Business opportunities for Regenrate

Compatibility /100

44/100

Medium potential

Why talk

  1. Complementary sectors: Agri & FoodTech × Biotech & life sciences — room for a joint offer or co-selling.
  2. Stage not comparable (Undetermined / Series A).
  3. Regenrate likely needs funding — ZymoChem (United States, Series A, $25M raised) can offer investor introductions (inferred from public profile).

Score anatomy

Each segment is what one dimension adds, out of 100.

Needs ↔ offers6.5Market bridge2.5Customer potential2.5Sector synergy25.0Stage complementarity7.5

Dimension by dimension

Needs ↔ offers

6.5 / 10 pts

Value flows both ways.

  • Regenrate likely needs funding — ZymoChem (United States, Series A, $25M raised) can offer investor introductions (inferred from public profile).
  • ZymoChem likely needs first paying customers — Regenrate can offer access to its customer base (inferred from public profile).

Market bridge

2.5 / 10 pts

Distant markets.

  • ZymoChem is based in United States (North America): a landing pad on another continent, both ways.

Customer potential

2.5 / 5 pts

Some customer potential.

  • Regenrate has the customers ZymoChem is still looking for — a channel Regenrate can open.

Sector synergy

25.0 / 50 pts

Complementary sectors.

  • Complementary sectors: Agri & FoodTech × Biotech & life sciences — room for a joint offer or co-selling.

Stage complementarity

7.5 / 25 pts

Weak stage signal.

  • Stage not comparable (Undetermined / Series A).

How the score works

Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Peers”: Needs ↔ offers 10, Market bridge 10, Customer potential 5, Sector synergy 50, Stage complementarity 25. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.

Potential blends compatibility (65%) with the mean global score of both startups (35%): 48/100 — high from 50, medium from 36.